risankizumab

Italy

Drugs containing this active substance

  • SKYRIZI

    Skyrizi is used for the treatment of several inflammatory diseases in adults: moderate to severe plaque psoriasis, psoriatic arthritis, moderate to severe Crohn's disease, and moderate to severe ulcerative colitis.

    Form: solution for injection

    Active substance Dosage
    risankizumab -

    ATC: L04AC18

    Manufacturer: ABBVIE DEUTSCHLAND GMBH & CO. KG